Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
08/13/2002 | US6432959 Antitumor agents |
08/13/2002 | US6432958 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands |
08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
08/13/2002 | US6432946 Psychological disorders; central nervous system disorders |
08/13/2002 | US6432921 Oligopeptides |
08/13/2002 | US6432879 Substituted phenyl uracils |
08/13/2002 | CA2111447C Hypoglycemic thiazolidinediones and intermediates |
08/08/2002 | WO2002060904A2 A process for the preparation of epothilone analogs |
08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
08/08/2002 | WO2002060444A1 Muscarinic receptor agonists |
08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
08/08/2002 | WO2002060374A2 Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
08/08/2002 | WO2001092991A3 Design of polyketide synthase genes |
08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
08/08/2002 | US20020107398 Microbicides in crop protection |
08/08/2002 | US20020107392 Quinolinone derivatives |
08/08/2002 | US20020107290 Inhibiting activated blood-coagulation factor X |
08/08/2002 | US20020107274 Potent inhibitors of cyclin dependent kinases; treating cancer or other proliferative diseases |
08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
08/08/2002 | US20020107252 Novel Compounds |
08/08/2002 | US20020106762 Generating preerential compound for use as prophylactic agent; obtain chemical intermediate, incubate with enzyme, recover prophylactic agent |
08/08/2002 | CA2672805A1 Pyrimidine derivatives |
08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
08/08/2002 | CA2434839A1 Muscarinic receptors agonists |
08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
08/07/2002 | EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
08/07/2002 | EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
08/07/2002 | EP1228062A1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines |
08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
08/07/2002 | EP1228051A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
08/07/2002 | EP1077976B1 Water soluble azoles as broad-spectrum antifungals |
08/07/2002 | EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof |
08/07/2002 | CN1362955A C7 ester substituted taxanes as antitumor agents |
08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
08/07/2002 | CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility |
08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
08/07/2002 | CN1088757C Process for preapring thiols |
08/07/2002 | CN1088709C Amine compound and its acid addition salt |
08/07/2002 | CN1088707C 2-carbonylthiazole derivatives and use of the same |
08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
08/07/2002 | CN1088587C Topical anti-inflammatory compositions containing piroxican |
08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
08/06/2002 | US6429206 Using agonist of nicotinergic acetylcholine receptors |
08/06/2002 | US6428667 Multichromophore fluorescent probes using DNA intercalation complexes |
08/06/2002 | CA2223237C 1-phenyl-pyrazole derivatives and their use as parasiticidal agents |
08/01/2002 | WO2002059121A1 Monomer for use in preparation of a polymer to be used in optical devices |
08/01/2002 | WO2002059120A1 Process for the preparation of isothiazole derivatives |
08/01/2002 | WO2002059119A1 Acylation of amino-isothiazoles using trialky-aluminium agents |
08/01/2002 | WO2002059118A1 Process for n-(oxyalkylation) of carboxamides |
08/01/2002 | WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
08/01/2002 | WO2002059115A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents |
08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |
08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
08/01/2002 | WO2002059108A1 Melanocortin receptor agonists |
08/01/2002 | WO2002059100A1 Halogen compounds having thrombopoietin receptor agonism |
08/01/2002 | WO2002059099A1 Cyclic compounds having thrombopoietin receptor agonism |
08/01/2002 | WO2002059098A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
08/01/2002 | WO2002059096A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives |
08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
08/01/2002 | WO2002010160A3 Substituted heterocyclyl alkylamino-1,3,5-triazines |
08/01/2002 | WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors |
08/01/2002 | US20020103387 Compounds which mimic the chemical and biological properties of discodermolide |
08/01/2002 | US20020103384 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV |
08/01/2002 | US20020103247 Indole and dihydroindole derivatives |
08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |